The global intravascular imaging market is poised for significant expansion, with projections indicating a value exceeding US$656.29 million by the year 2033. Based on industry estimates, this growth trajectory signifies a Compound Annual Growth Rate (CAGR) of 5.4%, building upon an estimated market size of US$387.8 million in 2023.
Intravascular imaging technologies are essential for cardiovascular diagnosis and therapies because they allow medical professionals to see into blood arteries and evaluate their structure and function. For patients with coronary artery disease (CAD) and other vascular conditions, these imaging modalities, which include intravascular ultrasound (IVUS) and optical coherence tomography (OCT), provide high-resolution images of the coronary arteries, facilitating precise diagnosis, treatment planning, and therapeutic guidance.
Claim Your Exclusive Report Sample Preview:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9926
Moreover, the COVID-19 pandemic has highlighted the significance of cardiovascular well-being and the necessity for inventive diagnostic and treatment approaches. Intravascular imaging plays an increasingly important role in improving long-term cardiovascular outcomes, decreasing procedural complications, and optimizing patient care as healthcare systems adjust to the pandemic’s challenges.
In an effort to cut healthcare expenses, physician offices and institutions are driving up demand for intravascular imaging. The need for cost-effectiveness, flexibility, and downsizing has contributed to the growing use of intravascular imaging systems.
It is anticipated that firms will continue to push the boundaries of technology in their diagnostic equipment manufacturing, driving intravascular imaging sales and expanding the intravascular imaging market share. Globally increasing rates of heart disease with coronary occlusion, deep vein thrombosis, and other illnesses are predicted to drive up patient traffic in diagnostic centers and propel the growth of the intravascular imaging market.
Key Takeaways:
- The United States is predicted to reach US$ 700 million by 2033.
- The United States is predicted to increase at a 5.6% annual rate.
- The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.
- China’s intravascular imaging industry is anticipated to be worthUS$850 million.
- The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.
“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.
Get Familiar With Our Methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9926
Competitive Landscape:
In order to boost their chances of making sales abroad, the top companies in the intravascular imaging market are working to expand the reach of their products. Interregional and international market companies working together, merging and acquiring, and forming partnerships are also anticipated to encourage the growth of the intravascular imaging market share.
Some of the top key players in the intravascular imaging market include Acqiris, NIDEK CO. LTD., AGFA Healthcare, Aculight Carl Zeiss AG, Heidelberg Engineering Inc., Optopol, Sonostar Technologies Co.Ltd., OPKO Health, AlazarTech and others.
- Siemens Healthineers implemented Luminos Impulse in September 2021, a fluoroscopy technology with an innovative layout and features shared by high-end fluoroscopy systems such as a seamless imaging chain, complete dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.
- Siemens Healthineers unveiled Somatom X.ceed in May 2021, a unique high-resolution, rapid speeds CT (computed tomography) scanner designed specifically for extremely demanding clinical applications where time and precision are critical.
- Avinger Inc. announced the entire business launch of their TigereyeTM image-guided chronic total occlusion (CTO) crossing system in January 2021.
Segmentation Analysis of the intravascular imaging Market
By Product Type:
- Instruments
- Software
By Modality:
- Handheld
- Trolley Mounted
By End User:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Long Term Care Centers
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/9926
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube